1. Human Costars Family Protein ABRACL Modulates Actin Dynamics and Cell Migration and Associates with Tumorigenic Growth
- Author
-
Bo-Yuan Hsiao, Chia-Hsin Chen, Ho-Yi Chi, Pei-Ru Yen, Ying-Zhen Yu, Chia-Hsin Lin, Te-Ling Pang, Wei-Chi Lin, Min-Lun Li, Yi-Chen Yeh, Teh-Ying Chou, and Mei-Yu Chen
- Subjects
actin regulator ,cell migration ,cofilin ,colorectal cancer ,tumorigenesis ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Regulation of cellular actin dynamics is pivotal in driving cell motility. During cancer development, cells migrate to invade and spread; therefore, dysregulation of actin regulators is often associated with cancer progression. Here we report the role of ABRACL, a human homolog of the Dictyostelium actin regulator Costars, in migration and tumorigenic growth of cancer cells. We found a correlation between ABRACL expression and the migratory ability of cancer cells. Cell staining revealed the colocalization of ABRACL and F-actin signals at the leading edge of migrating cells. Analysis of the relative F-/G-actin contents in cells lacking or overexpressing ABRACL suggested that ABRACL promotes cellular actin distribution to the polymerized fraction. Physical interaction between ABRACL and cofilin was supported by immunofluorescence staining and proximity ligation. Additionally, ABRACL hindered cofilin-simulated pyrene F-actin fluorescence decay in vitro, indicating a functional interplay. Lastly, analysis on a colorectal cancer cohort demonstrated that high ABRACL expression was associated with distant metastasis, and further exploration showed that depletion of ABRACL expression in colon cancer cells resulted in reduced cell proliferation and tumorigenic growth. Together, results suggest that ABRACL modulates actin dynamics through its interaction with cofilin and thereby regulates cancer cell migration and participates in cancer pathogenesis.
- Published
- 2021
- Full Text
- View/download PDF